| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $0 | — | — |
| R&D Expense | $993K | — | -48.6% |
| SG&A Expense | $804K | — | -34.9% |
| Operating Income | -$1.8M | — | +43.3% |
| Net Income | -$1.8M | — | +42.9% |
| EPS (Basic) | -$0.10 | — | +56.5% |
| EPS (Diluted) | -$0.10 | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | -27.8% | -70.9% |
| Current Assets | $1.3M | -25.0% | -69.0% |
| Total Assets | $8.4M | -5.3% | -28.8% |
| Current Liabilities | $1.2M | -9.5% | -27.6% |
| Total Liabilities | $1.2M | -7.7% | -26.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.6M | — | +38.6% |
| Capital Expenditures | $84K | — | +80.3% |
| Investing Cash Flow | -$84K | — | -80.3% |
| Financing Cash Flow | $1.2M | — | -27.2% |
| Free Cash Flow | -$1.7M | — | +36.5% |
| +56.5% |
| $7.2M |
| -4.6% |
| -29.0% |